Science Explorer Back to mapMap
Discussion
Company · Tartu · Estonia

Asper Biotech (Estonia)

asperbio.comROR OpenAlex
Research works
16
▲ 47% vs 2018-21
Citations
448
28.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
33%
world 40%
International
74%
world 18%
Asper Biotech (Estonia)

Not ranked overall: Asper Biotech (Estonia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Asper Biotech (Estonia) work in?

In all years, 67% of research at Asper Biotech (Estonia) is in Life Sciences, 20% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (55%), Medicine (20%), Neuroscience (7%). It does 2.5× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 67.3% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 54.6% of its workMolecular Biology: 5 fractional works · 28.8% of its workGenetics: 3 fractional works · 20.4% of its workCell Biology: 0 fractional works · 1.8% of its workCancer Research: 0 fractional works · 1.6% of its workBiophysics: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 7.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 3.7% of its workSensory Systems: 0 fractional works · 2.0% of its workNeurology: 0 fractional works · 1.3% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 3.7% of its workAnimal Science and Zoology: 0 fractional works · 2.0% of its workPlant Science: 0 fractional works · 1.5% of its workAgronomy and Crop Science: 0 fractional works · 0.4% of its workImmunology and Microbiology: 0 fractional works · 1.6% of its workImmunology: 0 fractional works · 1.1% of its workVirology: 0 fractional works · 0.5% of its workHealth Sciences: 3 fractional works · 20.2% of its workMedicine: 3 fractional works · 19.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.0% of its workGenetics: 0 fractional works · 2.6% of its workOphthalmology: 0 fractional works · 2.3% of its workOncology: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workEmergency Medicine: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workSurgery: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workPhysical Sciences: 2 fractional works · 10.9% of its workEngineering: 1 fractional works · 6.0% of its workBiomedical Engineering: 1 fractional works · 4.7% of its workMechanical Engineering: 0 fractional works · 1.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 2.1% of its workInorganic Chemistry: 0 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 2.1% of its workMaterials Chemistry: 0 fractional works · 2.1% of its workEnvironmental Science: 0 fractional works · 0.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 1.6% of its workDecision Sciences: 0 fractional works · 1.1% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.5% of its workALL ITS WORKAsper Biotech(Estonia)16fractional works, all years
Life Sciences67%Physical Sciences11%Health Sciences20%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology954.6%
    2. Neuroscience17.4%
    3. Agricultural and Biological Sciences13.7%
    4. Immunology and Microbiology01.6%
    1. Medicine319.5%
    2. Nursing00.7%
    1. Engineering16.0%
    2. Chemistry02.1%
    3. Materials Science02.1%
    4. Environmental Science00.7%
    1. Decision Sciences01.1%
    2. Psychology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Asper Biotech (Estonia)?

The most cited paper from Asper Biotech (Estonia) is "A first-generation linkage disequilibrium map of human chromosome 22" (Elisabeth Dawson et al., 2002), with 405 citations. Next come "Genotyping microarray (gene chip) for theABCR(ABCA4) gene" (241) and "Genotyping Microarray (Disease Chip) for Leber Congenital Amaurosis: Detection of Modifier Alleles" (178).

Most cited papers
#PaperReleasedCitations
1 A first-generation linkage disequilibrium map of human chromosome 22 Elisabeth Dawson et al. · Nature Open access 10 Jul 2002 405
2 Genotyping microarray (gene chip) for theABCR(ABCA4) gene Kaie Jaakson, Jana Zernant, Maigi Külm et al. · Human Mutation 25 Sep 2003 241
3 Genotyping Microarray (Disease Chip) for Leber Congenital Amaurosis: Detection of Modifier Alleles Jana Zernant, Maigi Ku ̈lm, Sharola Dharmaraj et al. · Investigative Ophthalmology & Visual Science 25 Aug 2005 178
4 Development of a genotyping microarray for Usher syndrome Cremers, F P M, et al, Fleischhauer, J C et al. · Zurich Open Repository and Archive (University of Zurich) Open access 2007 106
5 Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene Neeme Tõnisson, Jana Zernant, Ants Kurg et al. · Proceedings of the National Academy of Sciences Open access 16 Apr 2002 98
All 66 most cited papers, with filters and sorting

Which research topics does Asper Biotech (Estonia) publish most on?

By volume in 2022-now: Genetic factors in colorectal cancer, Genomics and Rare Diseases and Immunodeficiency and Autoimmune Disorders.

Genetic factors in color…0Genetic factors in colorectal cancer: 0 fractional worksGenomics and Rare Diseases0Genomics and Rare Diseases: 0 fractional worksImmunodeficiency and Aut…0Immunodeficiency and Autoimmune Disorders: 0 fractional works
Pathology and Forensic MedicineGeneticsImmunology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  2. 2 Genomics and Rare Diseases Genetics 0 works
  3. 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.8%not open67.2%

World: 40% of research is openly available.

with international co-authors74.1%domestic only25.9%

World: 18% is written across borders.

How has Asper Biotech (Estonia)'s research output changed?

Output in 2022-2025 was 47% higher than in 2018-2021.

20002005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Asper Biotech (Estonia) as a percentage of every work published that year, 0.0000035% in 2020.

0.000050%0.00010%0.00015%Asper Biotech (Estonia)0.0000046% in 2023200020102020

Fractional works of Asper Biotech (Estonia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tartu

All research institutions in Tartu

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Asper Biotech (Estonia). Posts are plain text and can be reported.